Literature DB >> 11244455

The effect of an increased free fatty acid concentration on thermogenesis and substrate oxidation in obese and lean men.

S L Schiffelers1, W H Saris, M A van Baak.   

Abstract

OBJECTIVE: To examine whether a certain increase in plasma free fatty acid (FFA) concentration leads to similar increases in lipid oxidation and energy expenditure in obese and lean men.
DESIGN: The study protocol consisted of a 30 min baseline period after which subjects received an i.v. bolus of 1000 IE heparin. Then consecutive infusions of 4.9, 9.8 and 19.6 microl/kg fat-free mass (FFM).min of a lipid heparin mixture were started, each infusion for 30 min.
SUBJECTS: Eleven obese and 13 lean men with a mean body mass index (BMI) of 34.2+/-1.0 (+/-s.e.m.) and 23.9+/-0.5 kg/m(2) and age 46.0+/-1.0 and 42.6+/-1.5 y, respectively. MEASUREMENTS: Energy expenditure, respiratory exchange ratio (RER) and carbohydrate and lipid oxidation were continuously measured by indirect calorimetry. At the end of each infusion period, a blood sample was taken for FFA, glycerol, insulin, beta-hydroxybutyrate, noradrenaline and adrenaline determination.
RESULTS: At baseline, plasma FFA levels were comparable in both groups. Lipid heparin infusion increased plasma FFA concentration by 301+/-47 micromol/l and 332+/-27 micromol/l in obese and lean men. Energy expenditure increased similarly in obese and lean men (0.34+/-0.08 vs 0.40+/-0.08 kJ/min, NS) during lipid heparin infusion, whereas RER decreased similarly in both groups. Lipid oxidation rates were comparable at baseline and increased similarly in obese and lean men (19+/-5 vs 13+/-4 mg/min, NS). Baseline plasma insulin levels were higher in the obese, but did not change during lipid heparin infusion. Plasma beta-hydroxybutyrate concentrations were similar at baseline, but increased significantly less in the obese during lipid heparin infusion. Baseline noradrenaline and adrenaline concentrations did not differ significantly between groups. During lipid heparin infusion, plasma noradrenaline levels decreased significantly, but plasma adrenaline levels remained unchanged in both groups.
CONCLUSION: A certain increase in plasma FFA concentration leads to similar increases in lipid oxidation and energy expenditure in obese and lean men. The accumulation of fat in obese subjects may therefore be more likely to be due to a defect in adipose tissue lipolysis than a defect in lipid oxidation. International Journal of Obesity (2001) 25, 33-38

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11244455     DOI: 10.1038/sj.ijo.0801528

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  13 in total

1.  Endoplasmic reticulum (ER) stress in cumulus-oocyte complexes impairs pentraxin-3 secretion, mitochondrial membrane potential (DeltaPsi m), and embryo development.

Authors:  Linda L Wu; Darryl L Russell; Robert J Norman; Rebecca L Robker
Journal:  Mol Endocrinol       Date:  2012-03-01

Review 2.  Contributions of adipocyte lipid metabolism to body fat content and implications for the treatment of obesity.

Authors:  Genevieve Marcelin; Streamson Chua
Journal:  Curr Opin Pharmacol       Date:  2010-06-08       Impact factor: 5.547

3.  A maximal effort trial in obese women carrying the beta2-adrenoceptor Gln27Glu polymorphism.

Authors:  T Macho-Azcárate; J Calabuig; A Martí; J A Martínez
Journal:  J Physiol Biochem       Date:  2002-06       Impact factor: 4.158

Review 4.  Dietary fat and sports nutrition: a primer.

Authors:  Lonnie M Lowery
Journal:  J Sports Sci Med       Date:  2004-09-01       Impact factor: 2.988

5.  Metabolic flexibility in response to glucose is not impaired in people with type 2 diabetes after controlling for glucose disposal rate.

Authors:  Jose E Galgani; Leonie K Heilbronn; Koichiro Azuma; David E Kelley; Jeanine B Albu; Xavier Pi-Sunyer; Steven R Smith; Eric Ravussin
Journal:  Diabetes       Date:  2008-02-19       Impact factor: 9.461

6.  Increased postprandial nonesterified fatty acid appearance and oxidation in type 2 diabetes is not fully established in offspring of diabetic subjects.

Authors:  François Normand-Lauzière; Frédérique Frisch; Sébastien M Labbé; Patrick Bherer; René Gagnon; Stephen C Cunnane; André C Carpentier
Journal:  PLoS One       Date:  2010-06-04       Impact factor: 3.240

Review 7.  Metabolic flexibility and insulin resistance.

Authors:  Jose E Galgani; Cedric Moro; Eric Ravussin
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-09-02       Impact factor: 4.310

8.  Identification of a selective glucocorticoid receptor modulator that prevents both diet-induced obesity and inflammation.

Authors:  José K van den Heuvel; Mariëtte R Boon; Ingmar van Hengel; Emma Peschier-van der Put; Lianne van Beek; Vanessa van Harmelen; Ko Willems van Dijk; Alberto M Pereira; Hazel Hunt; Joseph K Belanoff; Patrick C N Rensen; Onno C Meijer
Journal:  Br J Pharmacol       Date:  2016-04-24       Impact factor: 8.739

Review 9.  The discovery of drugs for obesity, the metabolic effects of leptin and variable receptor pharmacology: perspectives from beta3-adrenoceptor agonists.

Authors:  Jonathan R S Arch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-07-09       Impact factor: 3.000

10.  Substrate Utilization is Influenced by Acute Dietary Carbohydrate Intake in Active, Healthy Females.

Authors:  Sara Gregory; Richard Wood; Tracey Matthews; Deborah Vanlangen; Jason Sawyer; Samuel Headley
Journal:  J Sports Sci Med       Date:  2011-03-01       Impact factor: 2.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.